PolyPid raises $22 mln
PolyPid Ltd said Wednesday that it closed $22 million in private equity financing co-led by new investor Shavit Capital and current investor Aurum Ventures. Chaim Hurvitz, who will now head the Company's board of directors, also invested as well as other existing shareholder. PolyPid, of Petah Tikva, Israel, is a clinical-stage specialty pharmaceutical company.
24 February 2016•3 mins read
